FDA Investigator Jeanmaire Hryshko
Jeanmaire Hryshko has inspections in 1 countries as of 29 Sep 2023. Jeanmaire Hryshko has collaborated with a combined 1692 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
39
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adam S Freeman,
Andrew E Kay,
Andrew Tadros,
Angela D Wise,
Anh M Lac,
Anna J Vickrey,
Annie H Lam,
Bak,
Bracydc,
Breena L D'ambrogi,
Brett W Podoski,
Brian R Henderson,
Bruce D Broidy,
Capri R Woolridge,
Carl Lee,
Carol A Elems,
Carr,
Cindy W Lewis,
Courtney R Bolton,
Craig K Hopkins,
Cynthia L Ford,
Damon A Growl,
Darla R Bracy,
David A Laplante,
David J Leray,
Dirk L Lincoln,
Dustin P Tran,
Edna J Hidalgo,
Edwards,
Elisabeth A Drevet,
Emal Wahab,
Eric J Heinze,
Erica R Mahone,
Erica R Pomeroy,
Estefania Fernandez,
Gerard Pde Leon,
Gina M Hall,
Helen J Hamaoka,
Henry K Lau,
Ian J Thomson,
Ismael Garibay,
James C Lee, PharmD,
James C Yee,
Janice Wai,
Jazmine M Welcher,
Jennifer A Crumb,
Jennifer Crumb,
Jenny K Yee,
Jessica B Darneille,
John A Liu,
Jolene S Hedgecock,
Joseph M Willems,
Joseph Tibay,
Juliane Kjung Lau,
Kacie M Crowther,
Kaitlyn R Kornberg,
Karen D Phung,
Karla J Gibler,
Kenneth S Boehnen,
Kristin M Abaonza,
Krystina M Jackson,
Lea Lakes,
Lee,
Leongc,
Lija V Fellows,
Lila C Kraai,
Linda S Shook,
Lopez,
Lorraine N Williams,
LT Mark A Chen, MPH,
Lucila B Nwatu,
Luis A Solorzano,
Lynn L Wong,
Mabel M Lee,
Macropolk,
Maridali De Leon Torres,
Marissa J Chan,
Mark I Nakano,
Megan E Kulas,
Melody M Ragasa Leong,
Michael O Skidmore,
Nicole Yuen,
Nympha V Florendo,
Peter E Baker,
Quynh H Strandberg,
Randy L Elsberry,
Ronald P Boyce,
Rumany C Penn, PharmD,
Sandra S Saniga,
Siobhan A Gallagher,
State Agency,
Steven C Himebaugh,
Steven M Galvez,
Stuart Kim,
Stuart W Russell,
Suzanne M Crotty,
Thomas C Mclean, CFS,
Thomas N Adjabeng,
Timothy C Grome,
Travelle D Mason,
Victoria L Morgan,
Victoria Taylor,
Wen Jun Peng,
Wenting Lei,
William J Weis,
William V Millar
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more